Skip to content

Clinical Study On The Comparative Efficacy Of Qurs Asfar With ?im ?d Versus Sirka And Roghane Gul In Lichen Simplex Chronicus

Clinical Study On The Comparative Efficacy Of Qurs Asfar With Zimad Versus Sirka And Roghane Gul In Lichen Simplex Chronicus - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069520
Enrollment
38
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L280- Lichen simplex chronicus

Interventions

Intervention1: Roghan: Roghan Gul With Sirka Intervention2: Zimad and Qurs: 1. Zimad of Tukhm Khashkhash, Berg-e-Henna, Murdar Sang, Kunjad Muqasshar, Suhaga, Kafur, Roghan Gul Each 6g taken. All the

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All Clinically Diagnosed Subjects Of Lichen Simplex Chronicus Of Any Sex 2. Age 18 to 64 Years. 3. Presence Of At Least One Site Of Lichen Simplex Chronicus Of At Least 3cm In Width 4. Patient Who Will Give Consent And Is Able To Do Follow-up

Exclusion criteria

Exclusion criteria: 1. Patients aged less than 18 years or more than 64year 2. Pregnant or Lactating Women 3. Psychological conditions except for anxiety and depression 4. Lichen simplex chronicus associated with other cutaneous conditions and over the anogenital region and face 5. Patient who has taken treatment 2 weeks back

Design outcomes

Primary

MeasureTime frame
1. Decrease In Eczema Area And Severity Index Score 2. Decrease In PruritusTimepoint: 0th Day,7th Day,14th Day,21th Day,28th Day,35th Day

Secondary

MeasureTime frame
1. Improvement in Hospital Anxiety And Depression Scale 2. Change In Photography Of The LesionsTimepoint: 0th Day, 7th Day, 14th Day, 21th Day, 28th Day, 35th Day

Countries

India

Contacts

Public ContactProf Mohd Aleemuddin Quamri

National Institute Of Unani Medicine

sarimnium@gmail.com7767993333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026